The physiological and exercise performance adaptations to sprint interval training (SIT) may 21 be modified by dietary nitrate (NO3 -) supplementation. However, it is possible that different 22 types of NO3supplementation evoke divergent physiological and performance adaptations to 23 SIT. The purpose of this study was to compare the effects of 4 weeks SIT with and without 24 concurrent dietary NO3supplementation administered as either NO3 --rich beetroot juice (BR) 25 or potassium NO3 -(KNO3). Thirty recreationally-active subjects completed a battery of 26 exercise tests before and after a 4 week intervention in which they were allocated to one of 27 three groups: 1) SIT undertaken without dietary NO3supplementation (SIT); 2) SIT 28 accompanied by concurrent BR supplementation (SIT+BR); or 3) SIT accompanied by 29 concurrent KNO3 supplementation (SIT+KNO3). During severe-intensity exercise, V̇O2peak and 30 time to task failure were improved to a greater extent with SIT+BR than SIT and SIT+KNO3 31 (P<0.05). There was also a greater reduction in the accumulation of muscle lactate at 3-min of 32 severe-intensity exercise in SIT+BR compared to SIT+KNO3 (P<0.05). Plasma [NO2 -] fell to 33 a greater extent during severe-intensity exercise in SIT+BR compared to SIT and SIT+KNO3 34 (P<0.05). There were no differences between groups in the reduction in the muscle 35 phosphocreatine recovery time constant from pre-to post-intervention (P>0.05). These 36 findings indicate that 4 weeks SIT with concurrent BR supplementation results in greater 37 exercise capacity adaptations compared to SIT alone and SIT with concurrent KNO3 38 supplementation. This may be the result of greater NO-mediated signalling in SIT+BR 39 compared to SIT+KNO3. 40 41 42 3 New and Noteworthy: We compared the influence of different forms of dietary nitrate 43 supplementation on the physiological and performance adaptations to sprint interval training 44 (SIT). Compared to SIT alone, supplementation with nitrate-rich beetroot juice, but not KNO3, 45 enhanced some physiological adaptations to training. 46 47 48
49

Introduction
Incremental exercise tests single-leg knee extension exercise (over a distance of ~0.22 m) in a prone position within the 196 bore of a 1.5 T superconducting magnet (Gyroscan Clinical Intera, Philips, The Netherlands) 197 using a custom-built, non-ferrous ergometer at the University of Exeter Magnetic Resonance 198 Research Centre (Exeter, UK) as previously described (20, 62) . Each 24-s bout of high-199 intensity exercise (20 ± 4 W) was separated by 4 min. 31 P-MRS was used for the assessment 200 of muscle PCr recovery kinetics with data acquired every 1.5 s leading to a spectrum every 6 s 201 via a four phase cycle protocol. Due to technical issues with the scanner at the start of data 202 collection the subject number included in the analyses was restricted within each group to n = 203 9.
204
Measurements 205 Blood pressure 206 Before and following the intervention the BP at the brachial artery was measured using an 207 automated sphygmomanometer (Dinamap Pro: GE Medical Systems, Tampa, FL). Following 208 10 min seated rest in an isolated room, three measurements were recorded. The means of the 209 systolic and diastolic measurements were used for data analysis.
210
Blood analysis 211
Venous blood was sampled at rest (baseline) before each experimental test. Blood samples 212 were also obtained at 1-min, at 3-min and at exhaustion during the severe-intensity exercise 213 bout. The blood samples collected during the severe-intensity exercise bout were drawn from 214 a cannula (Insyte-WTM, Becton Dickinson, Madrid, Spain) inserted into the subject's X-100, Amresco, Salon, OH) before blood [lactate] and [glucose] were measured (YSI 2300, 220 Yellow Springs Instruments, Yellow Springs, OH). The remaining whole blood from each 221 sample was centrifuged at 4000 rpm for 8 min at 4 ºC within 2 min of collection. Plasma was 222 immediately extracted, frozen at -80 ºC and subsequently analyzed for [NO2 -] using 223 chemiluminescence, as previously described (68). Type IIx (%) 7 ± 15 6 ± 11 7 ± 9 4 ± 6 3 ± 2 2 ± 2
